Investor · New Haven, CT

Paul T. Estrem

Open Paul in the network graph →

Filings

14

SEC Form D

Connections

105

co-filers

Capital

$270.7M

across filings

Active

Oct 2016

to Dec 2020

Most-connected co-filers (105)

Michael A. Moceri · Chicago, IL10 shared Mark E. Jorgensen · San Francisco, CA10 shared David J. Winograd · Milwaukee, WI10 shared David F. Hale · San Diego, CA9 shared James B. Breitmeyer, M.D., Ph.D · San Diego, CA9 shared Erin T. Duffy · New Haven, CT8 shared Garheng Kong · Menlo Park, CA7 shared Damian Caldwell · Winston-Salem, NC7 shared Karen J. Jakobi · Irvine, CA7 shared David Fleshman · PALO ALTO, CA6 shared William R. Larue · San Diego, CA6 shared Carolin Steinmann · Pfaffikon, V86 shared Richard B. Vincent · San Diego, CA6 shared Michael G. Carter, M.D., Chb, Frcp · San Diego, CA5 shared Frank B. Hsu, M.D · San Diego, CA5 shared Gayle Troberman · New York, NY5 shared Thomas A. Roszak · Northfield, IL5 shared Steven Kay · San Francisco, CA5 shared Robert R. Wills, Ph.D · San Diego, CA5 shared Xin R. Nakanishi, Ph.D · San Diego, CA5 shared Charles R. Theuer · San Diego, CA5 shared Stan Johnson · Fargo, ND5 shared Allen R. Page · Waxahachie, TX5 shared Igor B. Bilinsky, Ph.D · San Diego, CA5 shared

Recent filings (14)

Oncternal Therapeutics, Inc.Dec 2020 · 38 co-filers$6.5M Oncternal Therapeutics, Inc.Nov 2020 · 38 co-filers$1.7M Oncternal Therapeutics, Inc.Sep 2020 · 38 co-filers$383K Oncternal Therapeutics, Inc.Aug 2020 · 40 co-filers$3.5M Oncternal Therapeutics, Inc.Jun 2020 · 40 co-filers$2.8M Oncternal Therapeutics, Inc.Nov 2018 · 25 co-filers$24.0M MELINTA THERAPEUTICS, INC. /NEW/Jan 2018 · 34 co-filers$137.8M MELINTA THERAPEUTICS, INC. /NEW/Nov 2017 · 36 co-filers$132.9M Oncternal Therapeutics, Inc.Sep 2017 · 21 co-filers$11.3M Oncternal Therapeutics, Inc.Mar 2017 · 26 co-filers$23.5M Oncternal Therapeutics, Inc.Dec 2016 · 29 co-filers$20.0M Groq, Inc.Dec 2016 · 8 co-filers$10.7M Oncternal Therapeutics, Inc.Oct 2016 · 29 co-filers$20.0M Groq, Inc.Oct 2016 · 8 co-filers$10.3M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Paul in the interactive graph →